 | • レポートコード：MRC2312MG07051 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、73ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の末梢血管用拡張薬市場規模と予測を収録しています。・世界の末梢血管用拡張薬市場：売上、2018年-2023年、2024年-2029年 ・世界の末梢血管用拡張薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の末梢血管用拡張薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「カルシウムチャネル遮断薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 末梢血管用拡張薬のグローバル主要企業は、Pfizer、 Novartis、 GSK、 AstraZeneca、 Merck、 Sanofi、 Bayer、 Abbott Laboratories、 Bristol Myers Squibb、 Boehringer Ingelheim、 Teva Pharmaceutical、 Viatris、 Sun Pharmaceutical Industriesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、末梢血管用拡張薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の末梢血管用拡張薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の末梢血管用拡張薬市場：タイプ別市場シェア、2022年 ・カルシウムチャネル遮断薬、α-アドレナリン遮断薬、カリウムチャネル活性化薬、その他 世界の末梢血管用拡張薬市場：用途別、2018年-2023年、2024年-2029年 世界の末梢血管用拡張薬市場：用途別市場シェア、2022年 ・病院、クリニック、薬局、その他 世界の末梢血管用拡張薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の末梢血管用拡張薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における末梢血管用拡張薬のグローバル売上、2018年-2023年 ・主要企業における末梢血管用拡張薬のグローバル売上シェア、2022年 ・主要企業における末梢血管用拡張薬のグローバル販売量、2018年-2023年 ・主要企業における末梢血管用拡張薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Pfizer、 Novartis、 GSK、 AstraZeneca、 Merck、 Sanofi、 Bayer、 Abbott Laboratories、 Bristol Myers Squibb、 Boehringer Ingelheim、 Teva Pharmaceutical、 Viatris、 Sun Pharmaceutical Industries ************************************************************* ・調査・分析レポートの概要 末梢血管用拡張薬市場の定義 市場セグメント 世界の末梢血管用拡張薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の末梢血管用拡張薬市場規模 世界の末梢血管用拡張薬市場規模：2022年 VS 2029年 世界の末梢血管用拡張薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの末梢血管用拡張薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の末梢血管用拡張薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：カルシウムチャネル遮断薬、α-アドレナリン遮断薬、カリウムチャネル活性化薬、その他 末梢血管用拡張薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、クリニック、薬局、その他 末梢血管用拡張薬の用途別グローバル売上・予測 ・地域別市場分析 地域別末梢血管用拡張薬市場規模 2022年と2029年 地域別末梢血管用拡張薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Pfizer、 Novartis、 GSK、 AstraZeneca、 Merck、 Sanofi、 Bayer、 Abbott Laboratories、 Bristol Myers Squibb、 Boehringer Ingelheim、 Teva Pharmaceutical、 Viatris、 Sun Pharmaceutical Industries ... |
This research report provides a comprehensive analysis of the Peripheral Vasodilators market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Peripheral Vasodilators market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Peripheral Vasodilators, challenges faced by the industry, and potential opportunities for market players.
The global Peripheral Vasodilators market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Peripheral Vasodilators market presents opportunities for various stakeholders, including Hospitals, Clinics. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Peripheral Vasodilators market. Additionally, the growing consumer demand present avenues for market expansion.
The global Peripheral Vasodilators market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Peripheral Vasodilators market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Peripheral Vasodilators market.
Market Overview: The report provides a comprehensive overview of the Peripheral Vasodilators market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Calcium Channel Blockers, Alpha-adrenergic Blockers), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Peripheral Vasodilators market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Peripheral Vasodilators market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Peripheral Vasodilators market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Peripheral Vasodilators market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Peripheral Vasodilators market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Peripheral Vasodilators market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Peripheral Vasodilators, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Peripheral Vasodilators market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Peripheral Vasodilators market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Calcium Channel Blockers
Alpha-adrenergic Blockers
Potassium Channel Activators
Other
Market segment by Application
Hospitals
Clinics
Retail Pharmacies
Other
Global Peripheral Vasodilators Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Pfizer
Novartis
GSK
AstraZeneca
Merck
Sanofi
Bayer
Abbott Laboratories
Bristol Myers Squibb
Boehringer Ingelheim
Teva Pharmaceutical
Viatris
Sun Pharmaceutical Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peripheral Vasodilators, market overview.
Chapter 2: Global Peripheral Vasodilators market size in revenue and volume.
Chapter 3: Detailed analysis of Peripheral Vasodilators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peripheral Vasodilators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Peripheral Vasodilators capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Peripheral Vasodilators Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peripheral Vasodilators Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peripheral Vasodilators Overall Market Size
2.1 Global Peripheral Vasodilators Market Size: 2022 VS 2029
2.2 Global Peripheral Vasodilators Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Peripheral Vasodilators Sales: 2018-2029
3 Company Landscape
3.1 Top Peripheral Vasodilators Players in Global Market
3.2 Top Global Peripheral Vasodilators Companies Ranked by Revenue
3.3 Global Peripheral Vasodilators Revenue by Companies
3.4 Global Peripheral Vasodilators Sales by Companies
3.5 Global Peripheral Vasodilators Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Peripheral Vasodilators Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Peripheral Vasodilators Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peripheral Vasodilators Players in Global Market
3.8.1 List of Global Tier 1 Peripheral Vasodilators Companies
3.8.2 List of Global Tier 2 and Tier 3 Peripheral Vasodilators Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Peripheral Vasodilators Market Size Markets, 2022 & 2029
4.1.2 Calcium Channel Blockers
4.1.3 Alpha-adrenergic Blockers
4.1.4 Potassium Channel Activators
4.1.5 Other
4.2 By Type – Global Peripheral Vasodilators Revenue & Forecasts
4.2.1 By Type – Global Peripheral Vasodilators Revenue, 2018-2023
4.2.2 By Type – Global Peripheral Vasodilators Revenue, 2024-2029
4.2.3 By Type – Global Peripheral Vasodilators Revenue Market Share, 2018-2029
4.3 By Type – Global Peripheral Vasodilators Sales & Forecasts
4.3.1 By Type – Global Peripheral Vasodilators Sales, 2018-2023
4.3.2 By Type – Global Peripheral Vasodilators Sales, 2024-2029
4.3.3 By Type – Global Peripheral Vasodilators Sales Market Share, 2018-2029
4.4 By Type – Global Peripheral Vasodilators Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Peripheral Vasodilators Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Retail Pharmacies
5.1.5 Other
5.2 By Application – Global Peripheral Vasodilators Revenue & Forecasts
5.2.1 By Application – Global Peripheral Vasodilators Revenue, 2018-2023
5.2.2 By Application – Global Peripheral Vasodilators Revenue, 2024-2029
5.2.3 By Application – Global Peripheral Vasodilators Revenue Market Share, 2018-2029
5.3 By Application – Global Peripheral Vasodilators Sales & Forecasts
5.3.1 By Application – Global Peripheral Vasodilators Sales, 2018-2023
5.3.2 By Application – Global Peripheral Vasodilators Sales, 2024-2029
5.3.3 By Application – Global Peripheral Vasodilators Sales Market Share, 2018-2029
5.4 By Application – Global Peripheral Vasodilators Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Peripheral Vasodilators Market Size, 2022 & 2029
6.2 By Region – Global Peripheral Vasodilators Revenue & Forecasts
6.2.1 By Region – Global Peripheral Vasodilators Revenue, 2018-2023
6.2.2 By Region – Global Peripheral Vasodilators Revenue, 2024-2029
6.2.3 By Region – Global Peripheral Vasodilators Revenue Market Share, 2018-2029
6.3 By Region – Global Peripheral Vasodilators Sales & Forecasts
6.3.1 By Region – Global Peripheral Vasodilators Sales, 2018-2023
6.3.2 By Region – Global Peripheral Vasodilators Sales, 2024-2029
6.3.3 By Region – Global Peripheral Vasodilators Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Peripheral Vasodilators Revenue, 2018-2029
6.4.2 By Country – North America Peripheral Vasodilators Sales, 2018-2029
6.4.3 US Peripheral Vasodilators Market Size, 2018-2029
6.4.4 Canada Peripheral Vasodilators Market Size, 2018-2029
6.4.5 Mexico Peripheral Vasodilators Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Peripheral Vasodilators Revenue, 2018-2029
6.5.2 By Country – Europe Peripheral Vasodilators Sales, 2018-2029
6.5.3 Germany Peripheral Vasodilators Market Size, 2018-2029
6.5.4 France Peripheral Vasodilators Market Size, 2018-2029
6.5.5 U.K. Peripheral Vasodilators Market Size, 2018-2029
6.5.6 Italy Peripheral Vasodilators Market Size, 2018-2029
6.5.7 Russia Peripheral Vasodilators Market Size, 2018-2029
6.5.8 Nordic Countries Peripheral Vasodilators Market Size, 2018-2029
6.5.9 Benelux Peripheral Vasodilators Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Peripheral Vasodilators Revenue, 2018-2029
6.6.2 By Region – Asia Peripheral Vasodilators Sales, 2018-2029
6.6.3 China Peripheral Vasodilators Market Size, 2018-2029
6.6.4 Japan Peripheral Vasodilators Market Size, 2018-2029
6.6.5 South Korea Peripheral Vasodilators Market Size, 2018-2029
6.6.6 Southeast Asia Peripheral Vasodilators Market Size, 2018-2029
6.6.7 India Peripheral Vasodilators Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Peripheral Vasodilators Revenue, 2018-2029
6.7.2 By Country – South America Peripheral Vasodilators Sales, 2018-2029
6.7.3 Brazil Peripheral Vasodilators Market Size, 2018-2029
6.7.4 Argentina Peripheral Vasodilators Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Peripheral Vasodilators Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Peripheral Vasodilators Sales, 2018-2029
6.8.3 Turkey Peripheral Vasodilators Market Size, 2018-2029
6.8.4 Israel Peripheral Vasodilators Market Size, 2018-2029
6.8.5 Saudi Arabia Peripheral Vasodilators Market Size, 2018-2029
6.8.6 UAE Peripheral Vasodilators Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Peripheral Vasodilators Major Product Offerings
7.1.4 Pfizer Peripheral Vasodilators Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Peripheral Vasodilators Major Product Offerings
7.2.4 Novartis Peripheral Vasodilators Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Peripheral Vasodilators Major Product Offerings
7.3.4 GSK Peripheral Vasodilators Sales and Revenue in Global (2018-2023)
7.3.5 GSK Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Peripheral Vasodilators Major Product Offerings
7.4.4 AstraZeneca Peripheral Vasodilators Sales and Revenue in Global (2018-2023)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Peripheral Vasodilators Major Product Offerings
7.5.4 Merck Peripheral Vasodilators Sales and Revenue in Global (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Peripheral Vasodilators Major Product Offerings
7.6.4 Sanofi Peripheral Vasodilators Sales and Revenue in Global (2018-2023)
7.6.5 Sanofi Key News & Latest Developments
7.7 Bayer
7.7.1 Bayer Company Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Peripheral Vasodilators Major Product Offerings
7.7.4 Bayer Peripheral Vasodilators Sales and Revenue in Global (2018-2023)
7.7.5 Bayer Key News & Latest Developments
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Summary
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories Peripheral Vasodilators Major Product Offerings
7.8.4 Abbott Laboratories Peripheral Vasodilators Sales and Revenue in Global (2018-2023)
7.8.5 Abbott Laboratories Key News & Latest Developments
7.9 Bristol Myers Squibb
7.9.1 Bristol Myers Squibb Company Summary
7.9.2 Bristol Myers Squibb Business Overview
7.9.3 Bristol Myers Squibb Peripheral Vasodilators Major Product Offerings
7.9.4 Bristol Myers Squibb Peripheral Vasodilators Sales and Revenue in Global (2018-2023)
7.9.5 Bristol Myers Squibb Key News & Latest Developments
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Company Summary
7.10.2 Boehringer Ingelheim Business Overview
7.10.3 Boehringer Ingelheim Peripheral Vasodilators Major Product Offerings
7.10.4 Boehringer Ingelheim Peripheral Vasodilators Sales and Revenue in Global (2018-2023)
7.10.5 Boehringer Ingelheim Key News & Latest Developments
7.11 Teva Pharmaceutical
7.11.1 Teva Pharmaceutical Company Summary
7.11.2 Teva Pharmaceutical Business Overview
7.11.3 Teva Pharmaceutical Peripheral Vasodilators Major Product Offerings
7.11.4 Teva Pharmaceutical Peripheral Vasodilators Sales and Revenue in Global (2018-2023)
7.11.5 Teva Pharmaceutical Key News & Latest Developments
7.12 Viatris
7.12.1 Viatris Company Summary
7.12.2 Viatris Business Overview
7.12.3 Viatris Peripheral Vasodilators Major Product Offerings
7.12.4 Viatris Peripheral Vasodilators Sales and Revenue in Global (2018-2023)
7.12.5 Viatris Key News & Latest Developments
7.13 Sun Pharmaceutical Industries
7.13.1 Sun Pharmaceutical Industries Company Summary
7.13.2 Sun Pharmaceutical Industries Business Overview
7.13.3 Sun Pharmaceutical Industries Peripheral Vasodilators Major Product Offerings
7.13.4 Sun Pharmaceutical Industries Peripheral Vasodilators Sales and Revenue in Global (2018-2023)
7.13.5 Sun Pharmaceutical Industries Key News & Latest Developments
8 Global Peripheral Vasodilators Production Capacity, Analysis
8.1 Global Peripheral Vasodilators Production Capacity, 2018-2029
8.2 Peripheral Vasodilators Production Capacity of Key Manufacturers in Global Market
8.3 Global Peripheral Vasodilators Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Peripheral Vasodilators Supply Chain Analysis
10.1 Peripheral Vasodilators Industry Value Chain
10.2 Peripheral Vasodilators Upstream Market
10.3 Peripheral Vasodilators Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Peripheral Vasodilators Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
